Long-term efficacy and safety of upadacitinib in patients with moderately to severely active ulcerative colitis: an interim analysis of the phase 3 U-ACTIVATE long-term extension study - Concepedia

Concepedia

Publication | Open Access

Long-term efficacy and safety of upadacitinib in patients with moderately to severely active ulcerative colitis: an interim analysis of the phase 3 U-ACTIVATE long-term extension study

DOI Full Paper Access

11

Citations

14

References

2025

Year

Remo Panaccione, Séverine Vermeire, Silvio Danese, Peter Higgins, Gary R. Lichtenstein, Hiroshi Nakase, Sarah C. Glover, Jean-Frédéric Colombel, Jason Eccleston, Michelle Kujawski,

The Lancet. Gastroenterology & hepatology

Abstract

AbbVie.

References

	Year	Citations

Page 1